| Best Home Health Care, Inc. | |
| 912 East 1st, Chandler, Oklahoma 74834 | |
| (405) 258-0035 | |
| Name | Best Home Health Care, Inc. |
|---|---|
| Location | 912 East 1st, Chandler, Oklahoma |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 377698 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 73003, 73008, 73013, 73020, 73026, 73034, 73054, 73072, 73084, 73105, 73106, 73107, 73109, 73110, 73111, 73112, 73114, 73115, 73119, 73120, 73127, 73129, 73130, 73135, 73139, 73149, 73150, 73159, 73160, 73162, 73165, 73170, 74026, 74079, 74801, 74832, 74834, 74854, 74855, 74857, 74873, 74875, 74881 |
| NPI Number | 1477599934 |
| Organization Name | PRAIRIE VIEW HOME HEALTH,INC. |
| Address | 515 E 1st St, Chandler, OK 74834 |
| Phone Number | 405-258-0035 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
| Quality Rating: |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 93.2 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 95.5 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.2 | 99.6 |
| How often the home health team checked patients for depression | 91.5 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 36.2 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 59.9 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.9 | 96.4 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 38.6 | 79.6 |
| How often patients got better at getting in and out of bed | 52.4 | 81.1 |
| How often patients got better at bathing | 38.5 | 82.3 |
| How often patients’ breathing improved | 26.8 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 28.4 | 75 |
| How often home health patients had to be admitted to the hospital | 16.1 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 15.1 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 88.1 | 94 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
The patient survey data of Best Home Health Care, Inc. is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 91 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 83 | 78 |
News Archive
RegeneRx Biopharmaceuticals, Inc. announced that it has received Orphan Drug designation from U.S. FDA's Office of Orphan Products Development for its drug candidate, Thymosin beta 4 (Tβ4), for the treatment of Neurotrophic Keratopathy, a serious degenerative disease of the corneal epithelium (the outside layer of the eye).
There is a large, untapped potential for developing drugs against cancer, fibrosis and cardiovascular diseases by targeting a family of receptors known as Frizzleds, researchers at Karolinska Institutet in Sweden believe. In a new study published in Science Signaling, they identify how these receptors are activated in the cell membrane and the processes that are then triggered within the cell.
A study of risk factors associated with psychotic illness after childbirth, published this week in the open-access journal PLoS Medicine, shows that first-time mothers are at the greatest risk of developing psychosis in the month following the birth of their child - even if they have never been treated in hospital for mental illness in the past.
Scientists at Southwest Foundation for Biomedical Research (SFBR) expect to make big leaps in their understanding of genetic influences on diabetes, thanks to a new $1.7 million grant awarded to Dr. Joanne Curran, the grant's principal investigator.
Every year, more strains of bacteria develop resistance to the antibiotics we use to treat deadly infections. At The Scripps Research Institute (TSRI) scientists have been working to develop new forms of these drugs, including an antibiotic called arylomycin—but tests have shown that it is possible for bacteria to become resistant to arylomycin, too.
› Verified 7 days ago
Best Home Health Care, Inc. Location: 912 East 1st, Chandler, Oklahoma 74834 Ratings: Phone: (405) 258-0035 |